Clinical trials
Placebo clinical trials
Below are recruiting placebo clinical trials, each written for real people, not researchers. We’re tracking 5,240 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06225752RecruitingPhase 3
Probucol for recent stroke or mini-stroke from narrowed arteries
This study tests whether the drug probucol can help people who recently had a stroke or mini-stroke caused by a narrowed artery in the brain or neck. It aims to reduce the risk of future strokes.
WuhuAges 40 years+ - NCT06226610RecruitingPhase 2
Testing dupilumab for severe itching after burn injuries
This trial tests if dupilumab (Dupixent) can help adults with long-lasting, severe itching from healed burn scars. It is for people whose itching has not improved with standard treatments like antihistamines.
Akron, OhioAges 18–60 - NCT06226025RecruitingPhase 2
Melatonin for Bipolar Disorder in Night Owls
This trial tests whether giving melatonin at the right time can help people with bipolar disorder who are night owls improve their mood and sleep. You would take melatonin or a placebo each evening for a few weeks while tracking your symptoms on a phone app.
Ann Arbor, MichiganAges 18–60 - NCT06226259Recruiting
GABA supplement for children with insomnia
This study tests whether a natural supplement called GABA can improve sleep in children ages 6 to 12 who have insomnia. It aims to find a safe, non-medication option for better sleep.
Shanghai, Shanghai MunicipalityAges 6–12 - NCT06226805RecruitingPhase 2
Testing BB-031 for recent ischemic stroke
This study tests an experimental drug called BB-031 to see if it can safely help people who have had a recent ischemic stroke (a clot that blocks blood flow to the brain). The trial is for people who can get to the hospital within 24 hours of their first symptoms and have a moderate to severe stroke.
Scottsdale, ArizonaAges 18 years+ - NCT06227910RecruitingPhase 3
Study of vedolizumab with or without upadacitinib for Crohn's disease
This trial tests combining two medicines, vedolizumab and upadacitinib, to see if they work better together than vedolizumab alone for people with moderate to severe Crohn's disease that hasn't responded well to other treatments.
La Jolla, CaliforniaAges 18–65 - NCT06229483RecruitingPhase 3
Does tranexamic acid reduce bleeding during brain tumor surgery?
This study tests whether a medication called tranexamic acid (TXA) given during brain tumor surgery can reduce bleeding. If you are having a standard craniotomy for a tumor and don’t have certain health risks, you may be eligible.
Halifax, Nova ScotiaAges 18–80 - NCT06229678RecruitingEarly Phase 1
Ketones and diabetes drug for heart failure with weak pump
This clinical trial looks at whether adding a special diet supplement (ketones) to an SGLT2 inhibitor diabetes drug improves heart function and symptoms in people who have both type 2 diabetes and heart failure with a weakened heart muscle.
San Antonio, TexasAges 18–70 - NCT06230718Recruiting
Thinking about moving your arm after stroke
This study tests if thinking about moving your arm (motor imagery) and watching a video of arm movements can help you move better after a stroke. It uses a technique called EMG to measure muscle signals while you try or imagine moving.
Salamanca, SalamancaAges 18–99 - NCT06230861Recruiting
Quercetin for Heart and Metabolic Health
This trial tests whether a natural plant compound called quercetin can improve markers of heart health and metabolism in healthy adults. It involves taking a quercetin supplement for a period of time.
Preston, LancashireAges 18–65 - NCT06231381RecruitingPhase 2
HB0034 for severe pustular psoriasis flare
This study tests an experimental drug called HB0034 for people with a sudden, severe flare of generalized pustular psoriasis (GPP). It aims to see if the drug can safely clear the pustules and improve symptoms.
BeijingAges 18–75 - NCT06234501Recruiting
Does vitamin B6 help sensory issues in autism?
This trial tests whether taking a daily 100 mg vitamin B6 supplement can help with sensory reactivity in autistic adults. It involves taking either the vitamin or a placebo (fake pill) for a set period and reporting how your senses (like touch, sound, or light) feel.
ReadingAges 18–60 - NCT06234631RecruitingPhase 2
CBD to reduce opioids after knee replacement
This study tests if a daily CBD capsule can help reduce the need for opioid pain pills after a first-time total knee replacement. It is for people with osteoarthritis who are having surgery and are willing to avoid cannabis for a short time before and after.
Ann Arbor, MichiganAges 18–80 - NCT06236503Recruiting
Brain stimulation for minimally conscious state
This trial tests a gentle brain stimulation technique called transcranial direct current stimulation (tDCS) to see if it can help people in a minimally conscious state. The goal is to improve awareness and responsiveness.
Messina, ItaliaAges 18–75 - NCT06237452RecruitingPhase 3
VE303 to prevent repeat C. diff infections
This trial tests a new medicine called VE303, a live bacterial therapy, to prevent C. diff infections from coming back. It is for people who have had C. diff at least once in the last 6 months, or who are at high risk for a repeat infection due to age or other health problems.
Huntsville, AlabamaAges 12 years+ - NCT06237153RecruitingPhase 2
Steroid injection for thumb arthritis pain
This study tests a long-acting steroid injection for thumb arthritis at the base of the thumb. It aims to reduce pain and improve function in people with mild to moderate joint damage.
Stony Brook, New YorkAges 18 years+ - NCT06238492Recruiting
Boosting brain speed after spinal cord injury
This trial tests a program to help improve how quickly your brain processes information after a recent spinal cord injury. It focuses on people who are about 6 months post-injury.
Englewood, ColoradoAges 18–59 - NCT06245109RecruitingPhase 4
Pain medicine study for knee osteoarthritis
This study tests how well different pain medicines work for knee osteoarthritis and looks at brain patterns to understand why some people get more relief. It may help you find a treatment that works best for you.
Chicago, IllinoisAges 41 years+ - NCT06247605RecruitingPhase 3
Study of AL8326 for advanced small cell lung cancer
This trial tests a new oral drug called AL8326 for people with advanced small cell lung cancer who have already tried at least two other treatments. The goal is to see if the drug can shrink tumors and help patients live longer.
Changchun, JilinAges 18 years+ - NCT06248229RecruitingPhase 4
Testing Dyanavel XR for fatigue in adults with ADHD
This trial tests whether the medication Dyanavel XR (a long-acting amphetamine) can help reduce fatigue in adults with ADHD. It is for people who have both ADHD and significant tiredness, and who are not currently taking stimulant ADHD drugs.
Rochester Hills, MichiganAges 18–65 - NCT06248671RecruitingPhase 2
Atorvastatin for preventing migraine attacks
This trial tests whether a daily dose of atorvastatin (a common cholesterol medicine) can prevent migraine attacks in people with episodic migraine. You would keep a headache diary and be randomly assigned to take atorvastatin or a placebo for about 3 months.
BergenAges 18–65 - NCT06249932RecruitingPhase 4
Empagliflozin for heart failure and end-stage kidney disease
This trial tests whether empagliflozin, a medication for heart failure, can help people who also have end-stage kidney disease and are on dialysis. It aims to see if the drug improves heart function in this group.
Hsinchu, TaiwanAges 20 years+ - NCT06249867RecruitingPhase 2
Darifenacin for ALS: safety and effect
This trial tests whether darifenacin, a drug currently used for bladder control, can safely help people with ALS. It aims to understand how the drug works in the body and if it can slow the disease or relieve symptoms.
Ottawa, OntarioAges 18–85 - NCT06249919RecruitingPhase 1/Phase 2
Study of NS101 for sudden hearing loss
This trial tests an experimental medicine called NS101 for people who have had a sudden, severe hearing loss in one ear that did not get better with standard steroid treatment. The goal is to see if NS101 can help restore hearing better than steroids alone.
Bucheon-siAges 19–70
Hear when a new Placebo trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for placebo?
- Yes. Clin2 currently lists 5,240 recruiting placebo studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a placebo trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a placebo trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.